MadhuB(Battu)ShettiMD

Radiation Oncology • San Pablo, CA

Physician

Join to view full profile

Dr. Shetti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Shetti's full profile

Already have an account?

Office
2000 Vale Rd
Doctors Medical Center - Cancer Center
San Pablo, CA 94806
Phone+1 313-871-9346
Is this information wrong?

Education & Training

University of WashingtonResidency, Radiation Oncology, 2007 - 2011
Henry Ford HospitalInternship, Transitional Year, 2006 - 2007
University of Michigan Medical SchoolClass of 2006

Certifications & Licensure

OR State Medical License 2016 - 2025
CA State Medical License 2010 - 2024
WA State Medical License 2007 - 2014
NY State Medical License 2011 - 2014
MI State Medical License 2006 - 2007
American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

17 citations
Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.
Saketh S. Dinavahi, Raghavendra Gowda, Christopher G. Bazewicz, Madhu Babu Battu, Jyh Ming Lin, Robert Chitren, Manoj K. Pandey, Shantu Amin, Gavin P. Robertson, Krish...> ;European Journal of Medicinal Chemistry. 2020 Feb 1
21 citations
Mycobacterium tuberculosis PPE2 Protein Interacts with p67phox and Inhibits Reactive Oxygen Species Production.
Shruti Srivastava, Madhu Babu Battu, Mehak Zahoor Khan, Vinay Kumar Nandicoori, Sangita Mukhopadhyay> ;Journal of Immunology. 2019 Sep 1
11 citations
Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent.
Saketh S. Dinavahi, Raghavendra Gowda, Krishne Gowda, Christopher G. Bazewicz, Venkat R. Chirasani, Madhu Babu Battu, Arthur Berg, Nikolay V. Dokholyan, Shantu Amin, G...> ;Molecular Cancer Therapeutics. 2019 Jan 1
7 citations
PPE65 of M. tuberculosis regulate pro-inflammatory signalling through LRR domains of Toll like receptor-2.
Rahila Qureshi, Nagender Rao Rameshwaram, Madhu Babu Battu, Sangita Mukhopadhyay> ;Biochemical and Biophysical Research Communications. 2019 Jan 1
19 citations
Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport.
Raghavendra Gowda, Gajanan S. Inamdar, Omer F. Kuzu, Saketh S. Dinavahi, Jacek Krzeminski, Madhu Babu Battu, Sreedhara R. Voleti, Shantu Amin, Gavin P. Robertson> ;Oncotarget. 2017 Mar 8
14 citations
Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast ca...
Hasitha Shilpa Anantaraju, Madhu Babu Battu, Srikant Viswanadha, Dharmarajan Sriram, Perumal Yogeeswari> ;Molecular Diversity. 2016 May 1
32 citations
Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
Patrisha Joseph Therese, Dinesh Manvar, Sridevi Kondepudi, Madhu Babu Battu, Dharmaranjan Sriram, Amartya Basu, Perumal Yogeeswari, Neerja Kaushik-Basu> ;Journal of Chemical Information and Modeling. 2014 Feb 5
9 citations
The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
Madhu B. Shetti, Gregory S. Merrick, Wayne M. Butler, Robert W. Galbreath, Ashley Torlone, Jonathan H. Lief, Edward Adamovich, Kent E. Wallner> ;American Journal of Clinical Oncology. 2012 Dec 1
27 citations
Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review.
Venkat Koushik Pulla, Madhu Babu Battu, Mallika Alvala, Dharmarajan Sriram, Perumal Yogeeswari> ;Expert Opinion on Therapeutic Targets. 2012 Jul 16
Join now to see all